Evidence map›Paper›PMID 41236227›Full record

ArticleDermatology practical & conceptual2025

Post-COVID Hair Loss in the Indian Subcontinent: Clinical Patterns and Association with Disease Severity.

Anshitha Vurimindi Kadudas, Tina Priscilla Katta, Neha Gala, Anu Mohandas, Manmohan Gavvala, Rishita Pogula, Sai Rashmitha Pagadala, Anvi K Reddy, Spurthi Subramanyam

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology practical & conceptual, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anshitha Vurimindi KadudasApollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India.
Tina Priscilla KattaDepartment of Dermatology, Venereology, Leprosy Apollo Institute of Medical sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India.
Neha GalaDepartment of Psychiatry, Apollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India.
Anu MohandasDepartment of Community Medicine, BGS Medical College and Hospital, Adichunchanagiri University, BGS Vijnatham Campus, Nagarur Bengaluru, Karnataka, India.
Manmohan GavvalaDepartment of Dermatology, Venereology, Leprosy Apollo Institute of Medical sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India.
Rishita PogulaApollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India.
Sai Rashmitha PagadalaApollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India.
Anvi K ReddyApollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India.
Spurthi SubramanyamApollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAs the pandemic plateaus, post-COVID alopecia is resurfacing in India. COVID-19 remains a pivotal cause of alopecia, and the diagnosis of post-COVID alopecia aids in better treatment outcomes.

objectivesTo estimate the prevalence of post-COVID alopecia and to evaluate the association between alopecia and COVID severity among other factors.

methodsA retrospective cross-sectional study was conducted among patients admitted to the COVID ward. Patients willing to participate were asked to fill in a pretested semi-structured questionnaire, and the PSS-10 (Perceived Stress Scale) was used to evaluate stress. Data were analyzed using the SPSS version 24.

resultsPrevalence of COVID-19-induced hair loss was 37.8%. Age, sex, COVID severity, and higher stress were the significant factors, with p-value <0.05. Female sex, COVID severity, and high stress levels came to be significant independent predictors of hair loss. A majority of participants (46.9%) noticed hair loss within three months of contracting the disease.

conclusionThis study stands to be a pioneer project to investigate the prevalence of COVID-19-induced alopecia in India. The prevalence rate of 37.8% with a significant association with severity of COVID-19 highlights the importance of reviewing patient history to provide proper treatment and reassurance.

Identifiers

PMID41236227
PMCPMC12615081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.